ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesB43

B43

ICD-10 title: Chromomycosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 B43 is a billable code used to indicate a diagnosis of icd-10 title: chromomycosis.

Key Diagnostic Point:

Chromomycosis is a chronic fungal infection of the skin and subcutaneous tissues caused primarily by dematiaceous fungi, such as Fonsecaea pedrosoi, Cladophialophora carrionii, and Phialophora verrucosa. This condition is characterized by the formation of nodular lesions, which can progress to ulceration and scarring if left untreated. Chromomycosis is often seen in tropical and subtropical regions, where the fungi thrive in soil and decaying vegetation. The infection typically occurs following trauma to the skin, allowing the fungi to enter the body. Patients with compromised immune systems, such as those with HIV/AIDS, diabetes, or undergoing immunosuppressive therapy, are at a higher risk for developing severe forms of chromomycosis. Diagnosis is usually made through clinical examination and confirmed by histopathological examination or culture of the organism. Treatment involves antifungal medications, such as itraconazole or terbinafine, and in some cases, surgical intervention may be necessary to remove infected tissue. Early diagnosis and appropriate management are crucial to prevent complications and improve patient outcomes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of causative organisms requiring specific identification.
  • Differentiation from other fungal infections.
  • Potential for chronicity and recurrence.
  • Need for comprehensive patient history, especially regarding immunocompromised status.

Audit Risk Factors

  • Inadequate documentation of the causative organism.
  • Failure to note immunocompromised status of the patient.
  • Misclassification of the infection as a different fungal disease.
  • Lack of detailed clinical notes regarding treatment response.

Specialty Focus

Medical Specialties

Infectious Disease

Documentation Requirements

Detailed patient history, including immunocompromised status and previous infections.

Common Clinical Scenarios

Patients presenting with chronic skin lesions, particularly in endemic areas.

Billing Considerations

Documentation of laboratory results confirming the fungal organism is crucial for accurate coding.

Dermatology

Documentation Requirements

Photographic evidence of lesions and detailed descriptions of clinical findings.

Common Clinical Scenarios

Patients with chronic dermatitis-like symptoms that do not respond to standard treatments.

Billing Considerations

Differentiating chromomycosis from other dermatological conditions is essential for accurate coding.

Coding Guidelines

Inclusion Criteria

Use B43 When
  • According to the official coding guidelines, B43 should be used when the diagnosis of chromomycosis is confirmed through clinical or laboratory findings
  • Coders should ensure that the documentation supports the diagnosis and treatment plan

Exclusion Criteria

Do NOT use B43 When
No specific exclusions found.

Related Codes

Child Codes

5 codes
B43.0
ICD-10 title: Pulmonary blastomycosis
B43.1
ICD-10 title: Pulmonary blastomycosis
B43.2
ICD-10 title: Pulmonary blastomycosis
B43.8
Other forms of candidiasis
B43.9
Candidiasis, unspecified

Related CPT Codes

11100CPT Code

Biopsy of skin, subcutaneous tissue

Clinical Scenario

Used when a biopsy is performed to confirm chromomycosis.

Documentation Requirements

Document the reason for the biopsy and the findings.

Specialty Considerations

Dermatologists should ensure that the biopsy results are linked to the diagnosis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of chromomycosis, improving the accuracy of data collection and reimbursement processes. It emphasizes the need for precise documentation of the causative organism and patient history.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of chromomycosis, improving the accuracy of data collection and reimbursement processes. It emphasizes the need for precise documentation of the causative organism and patient history.

Reimbursement & Billing Impact

reimbursement processes. It emphasizes the need for precise documentation of the causative organism and patient history.

Resources

Clinical References

  • •
    CDC Fungal Diseases

Coding & Billing References

  • •
    CDC Fungal Diseases

Frequently Asked Questions

What is the primary cause of chromomycosis?

Chromomycosis is primarily caused by dematiaceous fungi, which are found in soil and decaying vegetation. The most common species include Fonsecaea pedrosoi, Cladophialophora carrionii, and Phialophora verrucosa.

How is chromomycosis diagnosed?

Diagnosis is typically made through clinical examination, supported by histopathological examination or culture of the organism. A thorough patient history is also essential.

What treatments are available for chromomycosis?

Treatment usually involves antifungal medications such as itraconazole or terbinafine. In some cases, surgical intervention may be necessary to remove infected tissue.